Chiesi USA Revenue and Competitors
Estimated Revenue & Valuation
- Chiesi USA's estimated annual revenue is currently $105.1M per year.
- Chiesi USA's estimated revenue per employee is $201,000
Employee Data
- Chiesi USA has 523 Employees.
- Chiesi USA grew their employee count by 10% last year.
Chiesi USA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO - General Manager | Reveal Email/Phone |
2 | VP, Business Excellence and Customer Experience | Reveal Email/Phone |
3 | VP - Business Unit Leader, Special Care | Reveal Email/Phone |
4 | Head US Marketing, Special Care Business Unit | Reveal Email/Phone |
5 | VP and Head US Market Access ‑ Rare Diseases | Reveal Email/Phone |
6 | VP Specialty and Corporate Accounts | Reveal Email/Phone |
7 | Head Clinical Project Management, Rare Diseases | Reveal Email/Phone |
8 | VP Finance | Reveal Email/Phone |
9 | Head Late Phase Clinical Operations - US and Canada | Reveal Email/Phone |
10 | VP, Compliance | Reveal Email/Phone |
Chiesi USA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.8M | 29 | 4% | N/A | N/A |
#2 | $3.2M | 16 | 0% | N/A | N/A |
#3 | $83.2M | 414 | 7% | N/A | N/A |
#4 | $31M | 154 | 56% | N/A | N/A |
#5 | $66.6M | 265 | 0% | $35M | N/A |
#6 | $10.9M | 54 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -6% | N/A | N/A |
#8 | $165.7M | 216 | 14% | $250.7M | N/A |
#9 | $26.5M | 132 | -11% | $637.8K | N/A |
#10 | $49.4M | 246 | 6% | N/A | N/A |
What Is Chiesi USA?
Chiesi USA, Inc., headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercialization of products for the hospital, rare disease and target office-based specialties. Our employees take an entrepreneurial approach to meet the evolving needs of our customers. As a Public Benefit Corporation, Chiesi USA is committed to operating as a good corporate citizen; positively impacting communities in which we live and serve. Headquartered in Cary NC, we employ approximately 300 employees in the United States. Previously known as Cornerstone Therapeutics, the company was acquired by the Chiesi Group in 2014. Chiesi USA, Inc. is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. Headquartered in Parma, Italy, Chiesi Farmaceutici is an international research-focused group with more than 80 years of experience in the pharmaceutical industry. The Group employs more than 5,300 people in 27 affiliates worldwide, selling products in more than 80 countries. Chiesi is recognized as a top 50 company in terms of revenue and R&. Careers at Chiesi USA Inc: Email: Chiesiusa.jobs@chiesi.com Business Development: Email: us.busdev@chiesi.com All other inquiries: Email: us.contact@chiesi.com
keywords:N/A
N/A
Total Funding
523
Number of Employees
$105.1M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Chiesi USA News
CARY, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- Growth continues apace at Chiesi USA, (key-ay-zee), the U.S. affiliate of Chiesi Farmaceutici, an...
Chiesi USA, Inc. Chiesi Group turnover of 2.42bn supported by strong international growth of 8.6%. Growth across global markets, with...
As first announced in October 2021, as part of a Type A EndofReview meeting, the U.S. Food and Drug Administration (FDA), in principle, agreed...
CARY, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), today announced the publication of a cost-consequence analysis of KENGREAL® (cangrelor) in patients receiving percu ...
Chiesi Group currently employs 6,389 people worldwide, 2,119 of whom are in Italy, and has a turnover of €2.229 billion. Chiesi’s business comprises 30 affiliates, seven research centers, three production sites and a commercial presence in a total of 90 countries. These results are confirmation ...
Other Companies in Cary
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $138.1M | 539 | 2% | N/A |
#2 | $113.4M | 564 | 62% | N/A |
#3 | $85.2M | 568 | -1% | N/A |
#4 | $208.4M | 575 | 63% | N/A |
#5 | $233.5M | 582 | 4% | N/A |